Bionano Genomics Profit Margin 2017-2021 | BNGO
Current and historical gross margin, operating margin and net profit margin for Bionano Genomics (BNGO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Bionano Genomics net profit margin as of June 30, 2021 is -388%.
|Bionano Genomics Annual Profit Margins
|Bionano Genomics Quarterly Profit Margins
||Medical - Biomedical and Genetics
BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents. BioNano Genomics, Inc. is based in San Diego, United States.